Skip to main content

Scholar Rock Holding Corp

SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001727196

In the last 90 days, Scholar Rock Holding Corp insiders filed 0 open-market purchases and 5 sales; 306 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Scholar Rock Holding Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
5 insiders, $923.1K in total
Insiders trading
5
Net value
−$923.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Scholar Rock Holding Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Scholar Rock Holding Corp
NameTitleLast reported holdingLast filingFilings, past year
Woods KeithChief Operating Officer572,021Sep 25, 20264
Hallal DavidChief Executive Officer1,602,382Sep 23, 20265
Flier Jeffrey S.Director27,856Jul 6, 20262
Gilman MichaelDirector59,511Jul 6, 20262
Burow KristinaDirector114,657Jul 6, 20263
Reed JoshuaDirector19,518Jul 6, 20262
Peng KatieDirector34,301Jul 6, 20263
Akkaraju SrinivasDirector27,971Jun 8, 20263
Brudnick RichardDirector21,896Jun 8, 20261
Sinha VikasChief Financial Officer619,856Apr 20, 20263
Vaishnaw AkshayPresident of R&D630,542Apr 20, 20263
Qatanani MoCHIEF SCIENTIFIC OFFICER98,445Feb 25, 20267
Marantz Jing L.CHIEF MEDICAL OFFICER126,012Feb 19, 20263
Ho JunlinGENERAL COUNSEL241,545Feb 19, 20263
Parlavecchio CarynCHRO169,087Feb 19, 20263
Debbane Raymond10% Owner10,825,013Feb 6, 20261
Siren, L.L.C.10% Owner10,825,013Feb 6, 20261
Invus Global Management, LLC10% Owner10,825,013Feb 6, 20261
Sacco TraceyChief Commercial Officer71,750Apr 29, 20250
Moore ErinInterim PFO and PAO82,609Mar 25, 20250
Myles Edward HCOO & CFO111,345Mar 12, 20250
Backstrom Jay T.CHIEF EXECUTIVE OFFICER425,561Mar 12, 20250
Invus Public Equities Advisors, LLC10% Owner9,250,005Dec 12, 20240
Invus Public Equities, L.P.10% Owner9,250,005Dec 12, 20240
Nashat AmirDirector38,639May 13, 20240
Samsara BioCapital, L.P.10% Owner6,788,609IndirectOct 18, 20230
Samsara BioCapital GP, LLC10% Owner6,788,609IndirectOct 18, 20230
Artal Group S.A.10% Owner11,259,438Oct 16, 20230
Artal International S.C.A.10% Owner11,259,438Oct 16, 20230
Westend S.A.10% Owner11,259,438Oct 16, 20230
Stichting Administratiekantoor Westend10% Owner11,259,438Oct 16, 20230
Artal International Management S.A.10% Owner11,259,438Oct 16, 20230
Wittouck Amaury10% Owner11,259,438Oct 16, 20230
Mahanthappa Nagesh K.Interim CEO and President480,491Jun 21, 20220
Carven Gregory JohnChief Scientific Officer128,208Jun 21, 20220
Chyung Yung H.Chief Medical Officer258,496Feb 15, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 6, 2026 (view filing)4:30 PM ETJul 15 daysFlier Jeffrey S.DirectorSSale−3.05K$53.88−$164.5K−9.9%27.9K after3 lots10b5-1
Jul 6, 2026 (view filing)4:30 PM ETJul 15 daysGilman MichaelDirectorSSale−2.54K$53.87−$137.1K−4.1%59.5K after3 lots10b5-1
Jul 6, 2026 (view filing)4:30 PM ETJul 15 daysBurow KristinaDirectorSSale−3.05K$53.74−$164.1K−2.6%114.7K after2 lots10b5-1
Jul 6, 2026 (view filing)4:30 PM ETJul 15 daysReed JoshuaDirectorSSale−3.05K$53.74−$164.1K−13.5%19.5K after2 lots10b5-1
Jul 6, 2026 (view filing)4:30 PM ETJul 15 daysPeng KatieDirectorSSale−5.45K$53.88−$293.4K−13.7%34.3K after3 lots10b5-1
Apr 20, 2026 (view filing)Apr 164 daysWoods KeithChief Operating OfficerSSale−10.2K$49.57−$506.6K−1.6%620.1K after
Apr 20, 2026 (view filing)Apr 164 daysVaishnaw AkshayPresident of R&DSSale−12.2K$49.57−$607.0K−1.9%630.5K after
Apr 20, 2026 (view filing)Apr 164 daysSinha VikasChief Financial OfficerSSale−10.4K$49.57−$516.0K−1.7%619.9K after
Apr 20, 2026 (view filing)Apr 164 daysHallal DavidChief Executive OfficerSSale−30.6K$49.57−$1.52M−1.8%1.64M after
Feb 25, 2026 (view filing)Feb 232 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−8.48K$47.07−$399.3K−7.9%98.4K after3 lots10b5-1
Feb 19, 2026 (view filing)Feb 172 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−7.99K$46.53−$371.7K−7.0%106.9K after
Feb 19, 2026 (view filing)Feb 172 daysParlavecchio CarynCHROSSale−9.04K$46.53−$420.4K−5.1%169.1K after
Feb 19, 2026 (view filing)Feb 172 daysHo JunlinGENERAL COUNSELSSale−9.58K$46.53−$445.8K−3.8%241.5K after
Feb 19, 2026 (view filing)Feb 172 daysMarantz Jing L.CHIEF MEDICAL OFFICERSSale−4.16K$46.53−$193.4K−3.2%126.0K after
Jan 23, 2026 (view filing)Jan 221 dayQatanani MoCHIEF SCIENTIFIC OFFICERSSale−14.9K$46.71−$695.9K−14.8%85.7K after2 lots10b5-1
Jan 21, 2026 (view filing)Jan 165 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−8.41K$44.48−$373.9K−7.7%100.6K after
Jan 21, 2026 (view filing)Jan 165 daysParlavecchio CarynCHROSSale−6.60K$44.48−$293.6K−4.2%148.9K after
Jan 21, 2026 (view filing)Jan 165 daysHo JunlinGENERAL COUNSELSSale−8.02K$44.48−$356.6K−3.6%214.6K after
Jan 21, 2026 (view filing)Jan 165 daysMarantz Jing L.CHIEF MEDICAL OFFICERSSale−5.80K$44.48−$257.9K−5.7%95.7K after
Jan 16, 2026 (view filing)Jan 142 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−13.1K$45.20−$592.7K−10.7%109.0K after10b5-1
Jan 15, 2026 (view filing)Jan 132 daysSinha VikasChief Financial OfficerSSale−16.8K$42.70−$715.4K−2.8%583.2K after
Jan 15, 2026 (view filing)Jan 132 daysWoods KeithChief Operating OfficerSSale−16.7K$42.70−$715.1K−2.8%583.3K after
Jan 15, 2026 (view filing)Jan 132 daysVaishnaw AkshayPresident of R&DSSale−20.4K$42.70−$872.7K−3.3%595.8K after
Jan 15, 2026 (view filing)Jan 132 daysHallal DavidChief Executive OfficerSSale−57.5K$42.70−$2.45M−3.6%1.54M after
Dec 18, 2025 (view filing)Dec 162 daysPeng KatieDirectorSSale−1.01K$44.09−$44.4K−3.0%32.9K after2 lots10b5-1
Dec 16, 2025 (view filing)Oct 770 daysLateAkkaraju SrinivasDirectorPPurchase+29.6K$39.92+$1.18M+5.9%530.0K after3 lots
Dec 5, 2025 (view filing)Dec 41 dayQatanani MoCHIEF SCIENTIFIC OFFICERSSale−136.5K$45.21−$6.17M−55.6%109.0K after10b5-1
Oct 7, 2025 (view filing)Oct 3-64 daysAkkaraju SrinivasDirectorPPurchase+500.4K$37.58+$18.8MNew position500.4K after6 lots
Sep 24, 2025 (view filing)Sep 222 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−3.35K$30.67−$102.8K−3.0%109.0K after
Sep 17, 2025 (view filing)Sep 161 dayPeng KatieDirectorSSale−1.01K$32.53−$32.7K−2.9%33.9K after2 lots10b5-1
Sep 17, 2025 (view filing)Sep 161 dayQatanani MoCHIEF SCIENTIFIC OFFICERSSale−3.18K$33.52−$106.5K−2.8%112.3K after
Aug 19, 2025 (view filing)Aug 181 dayParlavecchio CarynCHROSSale−2.18K$31.17−$67.9K−1.4%155.5K after
Jul 18, 2025 (view filing)Jul 162 daysFlier Jeffrey S.DirectorSSale−11.1K$40.02−$445.7K−100.0%0 after10b5-1
Jul 10, 2025 (view filing)Jul 82 daysQatanani MoCHIEF SCIENTIFIC OFFICERSSale−24.1K$34.44−$828.8K−17.2%115.5K after10b5-1
Jun 25, 2025 (view filing)Jun 232 daysFlier Jeffrey S.DirectorSSale−20.3K$32.24−$655.0K−45.8%24.1K after2 lots10b5-1
Jun 25, 2025 (view filing)Jun 232 daysFlier Jeffrey S.DirectorSSale−11.1K$33.21−$369.8K−50.0%11.1K after10b5-1
Jun 17, 2025 (view filing)Jun 161 dayPeng KatieDirectorSSale−3.03K$31.97−$96.9K−8.0%34.9K after2 lots10b5-1
Jun 17, 2025 (view filing)Jun 161 dayQatanani MoCHIEF SCIENTIFIC OFFICERSSale−3.67K$32.00−$117.4K−2.6%139.6K after
Jun 17, 2025 (view filing)Jun 161 dayParlavecchio CarynCHROSSale−6.19K$32.00−$198.0K−3.8%157.6K after
Jun 17, 2025 (view filing)Jun 161 dayHo JunlinGENERAL COUNSELSSale−7.44K$32.00−$238.1K−3.2%222.6K after
May 30, 2025 (view filing)May 291 dayFlier Jeffrey S.DirectorSSale−6.08K$29.73−$180.6K−20.2%24.1K after2 lots10b5-1
May 30, 2025 (view filing)May 291 dayBurow KristinaDirectorSSale−5.40K$29.72−$160.5K−20.4%21.1K after2 lots10b5-1
May 30, 2025 (view filing)May 291 dayGilman MichaelDirectorSSale−3.38K$29.72−$100.3K−5.8%55.2K after2 lots10b5-1
May 30, 2025 (view filing)May 291 dayBrudnick RichardDirectorSSale−6.08K$29.72−$180.5K−28.7%15.1K after2 lots10b5-1
May 30, 2025 (view filing)May 291 dayReed JoshuaDirectorSSale−5.40K$29.71−$160.5K−25.6%15.7K after2 lots10b5-1
May 30, 2025 (view filing)May 291 dayVaishnaw AkshayPresident of R&DSSale−6.75K$29.72−$200.6K−1.1%616.2K after2 lots10b5-1
Apr 29, 2025 (view filing)Apr 254 daysSacco TraceyChief Commercial OfficerSSale−5.00K$32.82−$164.1K−6.5%71.8K after2 lots10b5-1
Mar 25, 2025 (view filing)Mar 241 daySacco TraceyChief Commercial OfficerSSale−6.50K$33.08−$215.0K−8.3%71.8K after2 lots10b5-1
Mar 25, 2025 (view filing)Mar 241 dayMoore ErinInterim PFO and PAOSSale−13.6K$33.12−$449.2K−14.1%82.6K after10b5-1
Mar 19, 2025 (view filing)Mar 172 daysPeng KatieDirectorSSale−1.01K$34.42−$34.6K−3.2%30.3K after10b5-1